高危儿童识别与随访可减轻1型糖尿病疾病严重程度并改善治疗结局
该研究比较了DIPP研究中126名经人群遗传筛查和前瞻性随访的高危儿童与440名筛查程序外诊断的儿童在1型糖尿病诊断时及1年治疗结局。DIPP参与者酮症酸中毒发生率(5.6% vs 23.6%)、脱水、电解质紊乱和重症监护需求显著更低,住院时间更短,诊断时和1年后HbA1c及胰岛素需求量均更低。结论为DIPP参与者在诊断时临床表现更轻,第一年HbA1c水平和胰岛素需求量更低。
要点
- 经人群遗传筛查和随访的高危儿童1型糖尿病诊断时酮症酸中毒发生率显著更低(5.6% vs 23.6%)。
- DIPP参与者诊断时和1年后HbA1c及胰岛素需求量均低于非筛查儿童。
- 筛查随访可减轻1型糖尿病诊断时疾病严重程度并改善第一年治疗结局。
核心结论
- DIPP参与者在1型糖尿病诊断时临床表现更轻,第一年HbA1c水平和胰岛素需求量更低。
研究设计与样本
- 比较DIPP研究中126名经人群遗传筛查和前瞻性随访的高危儿童与440名筛查程序外诊断的儿童在1型糖尿病诊断时特征及1年治疗结局。
主要发现
- DIPP参与者酮症酸中毒发生率显著更低(5.6% vs 23.6%,P < 0.05),脱水、电解质紊乱和重症监护需求更少,住院时间更短。
- DIPP参与者诊断时中位HbA1c为46 vs 99 mmol/mol(6.4 vs 11.2%),胰岛素需求量为0.11 vs 0.74 units/kg/day。
- 1年后DIPP参与者中位HbA1c为55 vs 61 mmol/mol(7.2 vs 7.7%),胰岛素需求量为0.57 vs 0.70 units/kg/day。
临床怎么用
- 对1型糖尿病高危儿童进行人群遗传筛查和前瞻性随访可能减轻诊断时疾病严重程度并改善早期治疗结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Interest in screening for type 1 diabetes (T1D) is increasing, but studies assessing outcomes during the treatment period among individuals identified through population-based genetic screening and prospective follow-up remain limited. RESEARCH DESIGN AND METHODS: Characteristics at T1D diagnosis and 1-year treatment outcomes were compared between 126 at-risk children followed in the Type 1 Diabetes Prediction and Prevention (DIPP) study and 440 children diagnosed outside the screening program. RESULTS: DIPP participants had significantly less frequent (P < 0.05) ketoacidosis (5.6% vs. 23.6%), dehydration, electrolyte imbalances, and need for intensive care, and shorter inpatient stays, than non-DIPP children. They showed lower median HbA1c levels (46 vs. 99 mmol/mol [6.4 vs. 11.2%]) and insulin requirements (0.11 vs. 0.74 units/kg/day) both at diagnosis and 1 year later (55 vs. 61 mmol/mol [7.2 vs. 7.7%]; 0.57 vs. 0.70 units/kg/day). CONCLUSIONS: DIPP participants had a milder clinical presentation at T1D diagnosis, with lower HbA1c levels and lower insulin requirements during the first year.
引用
- Kähkönen O, Kuusela S, Laiho JE, et al. Identification and Follow-up of At-Risk Children Mitigate Disease Severity and Improve Treatment Outcomes in Type 1 Diabetes. Diabetes Care. 2026. PMID: 42274414. doi:10.2337/dc26-0136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。